# DNA Capital

> DNA Capital is a VC fund in São Paulo backing Health Care and Medical. See 39 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: São Paulo, Brazil
- Total investments: 39
- Last investment: May 2026
- Lead investor: 49%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/dna-capital-br/
- Website: http://www.dnacapital.com/

DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.

## Contacts

5 contacts available for DNA Capital. Shizune tracks 7 team members at DNA Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/dna-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $250k–$8M |
| Series A | $2M–$30M |
| Series B | $4.6M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 20 | 51% |
| Medical | 10 | 26% |
| Health Insurance | 5 | 13% |
| Software | 4 | 10% |
| Wellness | 4 | 10% |

42 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 7 | 18% |
| Series A | 7 | 18% |
| Series B | 5 | 13% |
| Series C | 4 | 10% |
| Funding Round | 4 | 10% |

11 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 12 | 31% |
| Brazil | 9 | 23% |
| China | 1 | 3% |
| Senegal | 1 | 3% |
| Hong Kong | 1 | 3% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Carlos de Barros Jorge Neto | Partner | 0 | https://shizune.co/investors/profile/carlos-de-barros-jorge-neto |
| José Guinle | Partner | 1 | https://shizune.co/investors/profile/jos%C3%A9-eduardo-ribeiro-guinle |
| Luiz Felipe D Martins Costa | Managing Partner | 0 | https://shizune.co/investors/profile/luiz-felipe-d-martins-costa |
| Luiz Noronha | Partner | 11 | https://shizune.co/investors/profile/luiz-henrique-noronha |
| Mario Sergio Ribeiro | Partner | 0 | https://shizune.co/investors/profile/mario-sergio-ribeiro |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Memed | The safest and friendliest e-prescribing tool, for doctors. The most convenient and affordable way for treatment adherence, for patients. | $15.9M |  | May 21, 2026 |  |
| Reema Health | Reema Health is a technology startup transforming how people navigate the gaps between health care and social care. They believe that a personalized, community-based approach to care makes it easy for anyone to access the things they need to make their lives better. | $7.5M | Series A | Oct 10, 2024 |  |
| Piwi | Hi there, we are Piwi®. Like a broker, only easier. We didn’t create the company because we were in love with the market. It was exactly the opposite. With an easy to use and intuitive digital benefit managing platform we replaced the old school brokerage changing the way in which companies research, buy and manage their health plans and benefits.That’s evolution coming around! | $4M | Seed | Oct 01, 2022 |  |
| Sanar | Sanar seeks to reshape future doctors and healthcare professionals to be much more efficient and assertive. We started the company as a knowledge platform; from the first moment they step into college, we follow the evolution of the professional throughout their career. Today, Sanar has become a platform for doctors entire lives, offering solutionsfor different stages of their journey: 1 - For students we offer SanarFlix; the platform has a multitude of content from the best teachers in the country and is helping the students to overcome the challenges they face in college. 2 - For the period of admission to medical residency, Sanar offers Sanar Medical Residency, a platform for test preparation to help doctors to enter the best programs in Brazil. 3 - For the general physician, we offer SanarYellow, a clinical decision-making tool with the most up-to-date guidelines, protocols, and drug interactions for point-of-care. 4 - Sanar is also helping to unlock the doctor's potential with SanarUp, a credit product which offers additional income for the most difficult phases of their professional career. |  | Debt Financing | May 25, 2022 |  |
| Inspirali | Inspirali is an educational institute providing post-graduate training in the health sector. Inspirali provides comprehensive essential knowledge to help individuals develop and qualify their skills so they can become doctors of the future. Inspirali collaborates with partners who share the same vision, and together they move from productdevelopment to technological innovation, always with the goal of empowering future doctors who will democratize access to health. | $180.9M | Private Equity | Apr 01, 2022 |  |
| Reema Health | Reema Health is a technology startup transforming how people navigate the gaps between health care and social care. They believe that a personalized, community-based approach to care makes it easy for anyone to access the things they need to make their lives better. | $8M | Seed | Mar 30, 2022 |  |
| Nice Healthcare | Nice Healthcare is revolutionizing comprehensive healthcare for small and medium-sized businesses with technology and in-home care. Their services include in-home and virtual primary care, virtual mental health therapy, and virtual physical therapy. | $30M | Series A | Mar 10, 2022 |  |
| Cíngulo | Cíngulo offers emotional well-being through self-knowledge to improve self-esteem, mood, and attitude. |  | Seed | Mar 09, 2022 |  |
| Anima Educação | Anima Educacao also was known as GAEC Educacao SA, is an educational organization group that focuses on secondary education and universities. It also principally engaged in the educational sector.The Company's activities are divided into two segments: Higher education and Vertical management. It was founded on May 6, 2003, and is based inSao Paulo, Brazil. | $178.5M | Post-IPO Equity | Nov 29, 2021 |  |
| Inspirali | Inspirali is an educational institute providing post-graduate training in the health sector. Inspirali provides comprehensive essential knowledge to help individuals develop and qualify their skills so they can become doctors of the future. Inspirali collaborates with partners who share the same vision, and together they move from productdevelopment to technological innovation, always with the goal of empowering future doctors who will democratize access to health. | $178.5M | Secondary Market | Nov 29, 2021 |  |

10 of 39 investments shown.

## Co-investors
- [High Alpha](https://shizune.co/investors/profile/high-alpha-llc) — VC Fund, 5 deals together
- [Valor Capital Group](https://shizune.co/investors/profile/valor-capital) — VC Fund, 5 deals together
- [Banco Bradesco](https://shizune.co/investors/profile/banco-bradesco) — VC Fund, 3 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 3 deals together
- [Matchstick Ventures](https://shizune.co/investors/profile/matchstick-ventures) — VC Fund, 3 deals together
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [MS&AD Ventures](https://shizune.co/investors/profile/ms-ad-ventures) — VC Fund
- [Anthemis](https://shizune.co/investors/profile/anthemis-group) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [DOMO.VC](https://shizune.co/investors/profile/domo-invest) — VC Fund
- [Canary](https://shizune.co/investors/profile/canary-5) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in LATAM](https://shizune.co/investors/health-care-vc-funds-latam)
- [Health Care VC Funds in Brazil](https://shizune.co/investors/health-care-vc-funds-brazil)
- [Sports Investors in Brazil](https://shizune.co/investors/sports-investors-brazil)
- [InsurTech Investors in Asia](https://shizune.co/investors/insurtech-investors-asia)
- [InsurTech VC Funds in Asia](https://shizune.co/investors/insurtech-vc-funds-asia)
- [InsurTech Investors in China](https://shizune.co/investors/insurtech-investors-china)

## FAQ

### What does DNA Capital invest in?

DNA Capital invests primarily in Health Care, Medical and Health Insurance startups, most often at Seed and Series A stage. Most of the 39 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is DNA Capital's check size?

DNA Capital typically joins rounds of $250k–$8M at Seed, $2M–$30M at Series A and $4.6M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds DNA Capital participates in.

### How do I contact DNA Capital?

Public channels for DNA Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at DNA Capital?

The team at DNA Capital includes Carlos de Barros Jorge Neto (Partner), José Guinle (Partner) and Luiz Felipe D Martins Costa (Managing Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co